Keywords: پروموتر تومور; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CLL; B-cell chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; ERK; extracellular signal-regulated kinase; FN3; fibronectin type-III (domain); GBM; glioblastoma multiforme; JMML
مقالات ISI پروموتر تومور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite
Keywords: پروموتر تومور; Cholesterol; Oxysterol; Oncometabolism; Tumor promoter; Glucocorticoid receptor; Breast cancer; AEBS; antiestrogen binding site; ChEH; cholesterol epoxide hydrolase; Tam; Tamoxifen, trans-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; D8D7I
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
Keywords: پروموتر تومور; Protein kinase C; Phorbol ester; Tumor promoter; Tumor suppressor; Cancer therapy;
The see-saw of Keap1-Nrf2 pathway in cancer
Keywords: پروموتر تومور; Cancer; Keap1; Nrf2; Oxidative stress; Tumor suppressor; Tumor promoter;
The role of miRNA-223 in cancer: Function, diagnosis and therapy
Keywords: پروموتر تومور; miRNAs; MicroRNAs; UTR; The 3â² untranslated region; oncomiRs; Oncogenic miRNAs; miR-223; miRNA-223; T-ALL; T-cell acute lymphoblastic leukemia; AML; Acute myeloid leukemia; NSCLC; Nonsmall cell lung cancer; C/EBP; CCAAT-enhancer-binding protein; NFI-A;
Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma
Keywords: پروموتر تومور; Lysosome-associated protein transmembrane-4β; Human hepatocellular carcinoma; Tumor promoter; Proliferation; Migration; Invasion;
C-terminal tensin-like (CTEN): A promising biomarker and target for cancer
Keywords: پروموتر تومور; Cten; Tensin; Tumor promoter; Tumor suppressor; Focal adhesion;
SIRT3 and cancer: Tumor promoter or suppressor?
Keywords: پروموتر تومور; NAD+; Nicotinamide adenine dinucleotide; NAM; Nicotinamide; CR; Calorie Restriction; OSCC; Oral Squamous Cell Carcinoma; Sirtuin-3; SIRT3; Cancer; Tumor promoter; Tumor suppressor;
Modulation of protein kinase signaling cascades by palytoxin
Keywords: پروموتر تومور; Dual-specificity phosphatase; Mitogen activated protein kinase; Na+, K+-ATPase; Palytoxin; Tumor promoter
Is HCMV a tumor promoter?
Keywords: پروموتر تومور; Human cytomegalovirus; Glioblastoma; Oncomodulation; Tumor promoter
An international validation study of a Bhas 42 cell transformation assay for the prediction of chemical carcinogenicity
Keywords: پروموتر تومور; Cell transformation; Bhas 42 cells; v-Ha-ras; Tumor initiator; Tumor promoter;
Validation of an in vitro screening test for predicting the tumor promoting potential of chemicals based on gene expression
Keywords: پروموتر تومور; TPA; 12-O-Tetradecanoylphorbol-13-acetate; MeIQ; 2-amino-3,4-dimethylimidazo[4,5-f]quinoline; PhIP; 2-amino-1-methyl-6-phenylimidazo(4,5-B)pyridine; In vitro screening; Molecular marker; Transformation assay; Tumor promoter; Genotoxicity; Carcinogen;
Skin tumor promotion by argemone oil/alkaloid in mice: Evidence for enhanced cell proliferation, ornithine decarboxylase, cyclooxygenase-2 and activation of MAPK/NF-κB pathway
Keywords: پروموتر تومور; Argemone oil; Mouse skin; Tumor promoter; Cell proliferation; Signaling pathways
Comparison of gene expression profiles in BALB/c 3T3 transformed foci exposed to tumor promoting agents
Keywords: پروموتر تومور; BALB/c 3T3 cells; Tumor promoter; Cell transformation; cDNA microarray; Gene expression profile;
Hyalurondiase: Both a tumor promoter and suppressor
Keywords: پروموتر تومور; HA, hyaluronic acid; HAase, hyaluronidaseHyaluronidase; Hyaluronic acid; Tumor growth; Infiltration; Angiogenesis; Cancer diagnosis; Cancer prognosis; Tumor promoter; Tumor suppressor
Long-term 17α-ethinyl estradiol treatment decreases cyclin E and cdk2 expression, reduces cdk2 kinase activity and inhibits S phase entry in regenerating rat liver
Keywords: پروموتر تومور; 17α-ethinyl estradiol; Tumor promoter; Liver regeneration; Cell cycle block; Cyclin E; Cdk2; Cdk2 kinase activity.; EE; 17α-ethinyl estradiol; PH; partial hepatectomy; cdk; cyclin dependent kinase; PCNA; proliferation cell nuclear antigen; pRB; retinobl
Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways
Keywords: پروموتر تومور; Regulation of gene expression; Signal transduction; Tumor promoter; Protein phosphorylation; 12-O-Tetradecanoylphorbol-13-acetate; 5-Aminolevulinate synthase; Extracellular-signal regulated kinase; c-Jun N-terminal kinase; Phosphatidyl inositol 3-kinase;